News
Eli Lilly quickly disassociated itself from Hims & Hers after the telehealth company said it was selling the pharmaceutical ...
The Chief Executive of Eli Lilly has told the BBC that he is doubtful tariffs could bring manufacturing jobs to the US whilst ...
The EU executive and top pharmaceutical companies shared a video call to address concerns over potential US tariffs on drugs ...
Eli Lilly has launched weight-loss drug Mounjaro in India, priced at Rs 3,500 per injection for a 2.5mg dose. Will high costs ...
Needham hosted an expert to discuss potential impact of trade tariffs and personnel changes on healthcare equities. Generic ...
President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result ...
Primary care company knownwell said on Wednesday it will provide health and weight-management services on Eli Lilly's ...
Jazz Pharmaceuticals said on Tuesday that it had agreed to a settlement of $145 million to resolve a series of antitrust lawsuits related to its narcolepsy drug, Xyrem.
23h
Zacks Investment Research on MSNEli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should KnowEli Lilly (LLY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...
Sangamo Therapeutics has stacked up $18 million cash from Eli Lilly in a licensing deal that will let the pharma use the ...
Sangamo Therapeutics, Inc.'s $18M Eli Lilly deal boosts CNS genomic medicines. Fabry gene therapy data in 2025 is key for ...
The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results